Earnings Call Insights: Qiagen N.V. (NYSE:QGEN) Q4 2024 Thierry Bernard, CEO, highlighted that Qiagen surpassed its Q4 2024 ...
SOUTH SAN FRANCISCO, Calif., July 08, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next generation of ...
Presentation of encouraging preclinical results for CER-1236 in ovarian cancer, indicating potential effectiveness of the treatment. No observed toxicity in animal models after treatment, highlighting ...
TOULOUSE, France & ANN ARBOR, Mich.--(BUSINESS WIRE)-- Cerenis Therapeutics, a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and metabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback